Testosterone and Weight Loss

Phase 2

Completed

• Conditions: Obesity in Men
• Interventions: Drug: placebo; Drug: Testosterone

• Registration Number: NCT01616732
• Lead Sponsor: Austin Health

Brief Summary

The investigators hypothesise that testosterone therapy will synergize with dietary intervention to achieve weight loss. Obese men will receive diet, and be randomised to either testosterone therapy or placebo. Primary outcomes will be weight and body composition.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2012-06-08
• Study First Submitted QC: 2012-06-11
• Study First Posted: 2012-06-12
• Study Start: 2013-04
• Primary Completion: 2015-11
• Study Completion: 2015-12
• Status Verified: 2016-06
• Last Update Submitted: 2016-06-03
• Last Update Posted: 2016-06-06

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Male
• Target Recruitment: 100

Inclusion Criteria

• BMI >30

Exclusion Criteria

• contraindications to testosterone therapy

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
placebo	placebo	-
testosterone	Testosterone	against placebo

Primary Outcome Measures

Name	Time	Method
weight	12 months

Trial Locations

Locations (1)

Austin Health; 🇦🇺 Heidelberg, Victoria, Australia